We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The European Centre for Disease Prevention and Control (ECDC) reports continuing transmission of measles in European countries. From the beginning of 2023 to 9 May 2023 the following have been reported:
Previously, from January to March 2023, the WHO Regional Office for Europe (WHO EURO) reported 1 030 measles cases from European countries: Albania (3), Belarus (1), Belgium (2), Bosnia and Herzegovina (2), Estonia (1), France (4), Georgia (2), Italy (2), Kazakhstan (7), Kyrgyzstan (7), Poland (1), Russia (325), Serbia (40), Slovakia (1), Spain (4), Switzerland (5), Tajikistan (198), Turkey (343), Ukraine (3) and Uzbekistan (26).
Travel may increase an individual’s risk of exposure to measles virus, and facilitate the spread of disease to unvaccinated and susceptible populations. The travel consultation provides a valuable opportunity to ensure individuals are protected against measles, mumps and rubella (MMR) viruses. Two doses of MMR vaccine, at least one month apart, are required to give adequate protection.
Consider vaccinating:
For children, first and second doses of MMR vaccine can be administered earlier than they would routinely be given within the UK Vaccination Schedule (2 doses of MMR vaccine around 12-13 months, and before starting school at around 3 years 4 months of age).
See the TRAVAX Measles, Mumps and Rubella page for further information.